RDD PostersThe Poster Session at RDD 2024 presents research on all aspects of pulmonary and nasal drug delivery. The abstract submission deadline has passed, Because an unexpectedly large number of poster abstracts were submitted we have placed some of them on a waiting list as we work to secure space for additional posters boards. Abstracts on the waiting list will be entered into review in the order received and authors will be notified by e-mail.

Accepted abstracts will be published in the Conference Proceedings and those from graduate students will be automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award. The award covers registration fee, travel expenses and accommodation up to a maximum of $2000. Eligible student presenters should be prepared to answer questions from Virginia Commonwealth University’s judging panel.

Posters on the Podium will showcase editor-selected posters from presenters who have travelled to Arizona during a series of ten-minute live presentations in the main auditorium followed by a fast-paced Q&A session.

When and Where?

Posters will be continuously accessible to delegates from 10:00 AM until 7:00 PM on Monday, May 6 and from 8:30 AM to 7:00 PM on Tuesday, May 7 in the Tucson Ballroom. The Poster and Exhibition Session will be the only RDD event during the following times:

To ensure maximum visibility and networking, posters and exhibition tables will be thematically arranged in Knowledge Spaces.

Poster Presentations

If the status of your Poster Abstract in this Table is not what you expected, please check your spam folder for an e-mail from our editorial team.

JC
Access to Advanced Health Institute
John Chen
Accelerated Stability and Aerosol Performance Assessment for a Spray Dried Nasal COVID-19 Vaccine Candidate
In Publication
JC
Access to Advanced Health Institute
John Chen
Process Modeling for Small-Scale Manufacturing of Spray Dried Nasal Vaccine Powders
In Publication
Amneal Pharmaceuticals
Sunilkumar Patel
The Influence of Temperature and Humidity Control in Laboratory Settings on the Aerodynamic Particle Size Distribution of Soft Mist Inhalers
In Publication
Goncalo Farias and Charles Cazzola
Optimization of a Multidose Nasal Actuator Targeting Olfactory Region Deposition
In Publication
BG
Pauline Faucard and Benedicte Grosjean
Leachables Assessment from a New Generation of pMDIs using Low Global Warming Potential Propellants and the Impact of Ethanol Filling
In Publication
Astartein
Anthony Hickey
Electronic Facemask to Enhance Patient Compliance
In Publication
Belhaven Biopharma
Brian Taubenheim
Pharmacokinetic Comparison of Nasal Delivered Dry Powdered Epinephrine to an Autoinjector (EpiPen®) in a Canine Model
In Publication
Sabrina Falloon
Using Human Factors Studies to Optimize Nozzle Geometry for Patient Interaction in the Design Development of a Unit Dose Nasal Spray
In Publication
Lei Mao
Development of Albuterol Sulfate Pressurized Metered Dose Inhalers using a Low Global Warming Potential Propellant 1,1-difluoroethane (HFA152a)
In Publication
Lei Mao
Development of Beclomethasone Dipropionate Pressurized Metered Dose Inhalers using a Low Global Warming Potential Propellant, 1,3,3,3-tetrafluoropropene (HFO1234ze)
In Publication
Benjamin Thorne
Investigating the Impact of Device Design and Propellant Choice on the Aerosolization of Fluticasone Propionate Suspensions in HFA152a and HFO1234ze
In Publication
Jufang Xu
Aerodynamic Characteristics of Spiriva® Handihaler® at Simulated Breathing Patterns of COPD and Healthy Subjects, and at a Constant Inhalation Flow using One Capsule per Determination
In Publication
Clair Brooks
Reducing Variability in the Inhaler Testing Environment
In Publication
Mirjam Kobler
Advancing DPI Technology: A Modular Approach on Optimizing Capsule Movement for Improved Performance
In Publication
Ameet Sule
Designing a Sustainable Ipratropium HFA-152a pMDI: Actuator Geometry Considerations
In Publication
Irene Rossi
Ellipta® Blister Device: A Re-Assembly Set of Tools for Early In Vitro Comparative Studies of a Complex Pre-Metered Dry Powder Inhaler
In Publication
Erik Boldt and Gregory Smith
Two Isn’t Always Better Than One: A Single-Actuation Salbutamol Sulfate Metered Dose Inhaler Using Low-GWP Propellant HFO-1234ze(E)
In Publication
Patricia Henriques and Dina Morais
Systemic Nasal Absorption of Amorphous Solid Dispersions: Supersaturating Systems for Fast Onset of Action of Poorly Soluble Drugs through the Nasal Mucosa
In Publication
JP
Maria Ines Lopes and Joao Pires
Drug Load Influence on Aerodynamic Properties of High Dosage DPIs: A Case Study of an Aminoglycoside Model Drug
In Publication
AR
Alexandre Ribeiro
Differential Permeability of Dry Solid and Aqueous Suspensions of Fluticasone Propionate Through A549 Alveolar Epithelial Cells
In Publication
Lidia Santos and Claudia Costa
Understanding Leucine Encapsulation in Dry Powder Inhaler Microparticles via Surface Characterization Techniques
In Publication
Jakob Samsøe and Måns Osterberg Widerstrand
Novel Inhaled Anti-Viral Against SARS-CoV-2: Feasibility of Developing a Nanofitin Dry Powder Formulation for Pulmonary Delivery using the ICOone Single Dose Dry Powder Inhaler
In Publication
EHLS
ImmuONE
Ewelina Hoffman and Louis Scott
High-Content Image Analysis for Phenotypic Characterization of Foamy Macrophage Responses of Alveolar Macrophages to Amiodarone
In Publication
InformiX Pharma
Parmesh Gajjar and Darragh Murnane
Novel Insight into the Microstructure of Fines-Only Formulations using X-ray Computed Tomography with Machine Learning
In Publication
Barry Clements
The Impact of the Universal Spacer System on Efficiency and Reliability of Dose Delivery of Inhaled Nebulized Aerosols
In Publication
Svetlana Lyapustina
Regulatory Topics in Nasal Product Development: Pediatrics and Reliability Expectations
In Publication
Jolyon Mitchell
Laser Diffraction Size Analysis of Products for Nasal Inhalation: A Survey of Expert Users
In Publication
Johannes Gutenberg-Universität Mainz
Moritz Fleischhauer
Tuning the Aerosol Delivery of the Respimat® Soft Mist Inhaler
In Publication
James Drake
Practical Considerations for Conducting Successful In Vitro Bioequivalence Studies on Inhalers
In Publication
SS
Sally Stanford
An Assessment of the Effect of Vacuum Crimping on Dry Powder Filled pMDI Cans
In Publication
Sana Hosseini and Kimberly Shepard
Formulation of an Intranasal Dry Powder Vaccine Candidate for Tuberculosis
In Publication
Neerja Zambare and Kimberly Shepard
Manufacturability of Intranasal Dry Powders Spray Dried from Aqueous Solutions
In Publication
Ludwig-Maximilians-University Munich
Katrin Wiebe and Simone Carneiro
Impact of Vibrating Mesh Nebulization on the Physicochemical Properties of mRNA and siRNA Lipid Nanoparticle Formulations
In Publication
Mridul Majumder
Application of Raman Spectroscopy for Dry Powder Inhalation Formulation
In Publication
Macquarie University
Chun Yuen Jerry Wong
Enhancing Nose-to-Brain Drug Delivery: A Comparative Study of Peptide Formulations Using a Multidose Nasal Spray
In Publication
DCMG
Medisch Spectrum Twente
Dumiana Chamaon and Martijn F. Grinovero
Validation of the RS01X™ Smart Inhaler in a Clinical Setting
In Publication
Monash University
Daniel Duke
Effects of Low Global Warming Potential Propellants HFA152a and HFO1234ze(E) on the Morphology of Suspension Based Pressurized Metered Dose Inhaler Sprays
In Publication
Monash University
Rina Perven
The Fluid Dynamics of a Dry Powder Inhaler Assisted with a Zero-Net-Mass-Flux Jet
In Publication
Monash University
Lingzhe Rao and Daniel Duke
Manipulation of pMDI Spray Morphology via Orifice Length Variation with Propellants HFA134a, HFA227, HFA152a and HFO1234ze(E)
In Publication
Monash University
Swetha Chowdary Vutlapalli and Daniel Duke
Measurement of Vapor Pressure and Viscosity of Ethanol in HFA134a, HFA152a, and HFO1234ze(E) Mixtures used in pMDIs
In Publication
Will Ganley
Utilizing Physiologically-based Modeling for the Design of an Inhaled Powder Formulation of Imipenem Aimed at Maximizing the Dose Delivered to the Lung Lining Fluid
In Publication
Nuria Manzano and Will Ganley
Comparative Assessment of Plume Velocity in pMDI Solutions: A Study using Phase Doppler Anemometry and SprayView Analysis
In Publication
Nebu-Flow
Neil Fullarton
Ultrafine siRNA-laden Aerosol Using Next Generation Nebulizer
In Publication
Orexo AB
Jonas Sävmarker
Spray Dried Amorphous Epinephrine Nasal Powder for the Acute Treatment of Anaphylaxis
In Publication
Daniel Lewis
Case Studies on Reformulation of BDP MDIs using Low GWP Propellants HFO1234ze and HFA152a
In Publication
MS
Andrea Winzen and Martin Schlun
Aerosol Performance and Usability Evaluation of New Pediatric Facemasks for a Valved Holding Chamber
In Publication
Timothy Fallon and Deborah Jones
Inhalation and Exhalation Airflow Resistance of Valved Holding Chambers
In Publication
Lynn Jordan
Methodology for Measurement of Evaporation Fraction and Evaporation Rate: A Comparison of HFA-134a and HFA-152a pMDI Formulations
In Publication
Carolina Dantas
Examining User Breathing Patterns During Nebulization with a Guided Inhalation Maneuver
In Publication
Purdue University
Kinnari Arte
Impact of L-leucine on Stability and Aerosol Performance of Dry Powder Protein Formulations
In Publication
Purdue University
Shruti Sawant
Liposomal Formulation Reduces Cell Uptake of Bacteriophage in a Lung Epithelial Cell Model
In Publication
Resyca
Nicolas Buchmann
Assessing the Variability of In Silico Lung Deposition Predictions When Inhaling from Soft Mist Inhalers with Various Air Flow Resistances
In Publication
RTI International
Sara Maloney Norcross
Physicochemical and Aerodynamic Stability of Spray Dried Tigecycline Inhalation Powder for the Treatment of Pulmonary Nontuberculous Mycobacterial Infections
In Publication
Scientific Consultant
Loy Britto
Development of an MDI Coated Can with a Non-PFAS Polymeric Coating
In Publication
Yannick Baschung
Unlocking the Promise of Digital Inhalers: Insights from an In Vitro Study
In Publication
St. John's University
Alec Diorio
The Anti-Microbial Peptide, H1b, for Non-Small Cell Lung Cancer Treatment: Dry Powder Formulation Development And Characterization
In Publication
The University of Texas at Austin
Varsha Nair and Rex Moore
Lipid-Based Spray Dried Microparticles of Monoclonal Antibodies for Inhalation
In Publication
The University of Texas at Austin
Mike Sandoval and Alan Watts
Drum Filling of Thin-Film Freeze-Dried Monoclonal Antibody Powders into a Nasal Spray System
In Publication
The University of Texas at Austin
Jamie Spahn
A Comparison of the Aerosol Dispersion of Twelve Micronized Powders
In Publication
Mark Nagel
Effect of Flow Rate on Emitted Aerodynamic Particle Size Distribution from a Dry Powder Inhaler Delivering a Short-Acting Beta2 Agonist as Monotherapy
In Publication
SB
U.S. Food & Drug Administration
Susan Boc
Characterization of Spray-Dried Phospholipid Porous Particles for Inhalation Drug Delivery
In Publication
U.S. Food & Drug Administration
Steven Chopski
Novel Method for Aerodynamic Particle Size Distribution Measurements from Respimat® Inhalers
In Publication
NH
U.S. Food & Drug Administration
Nicholas Holtgrewe
Development of an In Vitro Method for In Vivo Prediction of Regional Deposition of Nasal Powders
In Publication
ML
U.S. Food & Drug Administration
Nathan Reed and Markham Luke
Characterizing Adasuve® (Loxapine, 10 mg) Inhalation Powder Particle Size Distribution Using Laser Diffraction
In Publication
U.S. Food & Drug Administration
Ross Walenga
Sensitivity of Charcoal Block PK Metrics to Differences in Regional Deposition for Budesonide and Formoterol Fumarate Dihydrate
In Publication
Universidade Estadual de Campinas
Laura Oliveira Nascimento
Effects of Surfactant Coating on Levofloxacin-Loaded Nanoparticles: Impact on Physicochemical Properties and In Vitro Cell Viability of Pulmonary Cells 
In Publication
Universidade Estadual de Campinas
Victoria Soares Soeiro
Enhancing Polymeric Nanodispersions for Improved Doxycycline Efficacy Against Lung Pathogen Biofilms
In Publication
BJ
University of Alabama at Birmingham
Blessy Joseph
The Use of Atomic Force Microscope-Infrared Spectroscopy to Assess Co-Localization of Fluticasone/Salmeterol/Lactose in Advair Diskus® 100/50 Formulations
In Publication
University of Bristol
Yiliang Jiang
Tandem Aerodynamic Particle Sizers Method for the Characterization of Aerosol Dynamics at Different Relative Humidities
In Publication
University of Hong Kong
Han Cong Seow
The Influence of Salts on Spray Dried Powder for Nasal Inhalation: Aerosol Characterization with 3D-Printed Nasal Replica
In Publication
University of Michigan
Nishant Shah
Evaluating Published Artificial Mucus Models for Understanding Predictability of Inhaled Drug Delivery Dynamics
In Publication
University of Michigan
Grace Xia
Optimization of Carbohydrate Excipient Ratios in Respirable Protein Powder Formulations
In Publication
University of Oklahoma
Alexa Beathard
Aerosol Performance of OHet72 Nanosuspensions Nebulized into a Custom-Made Nose-Only Dosing Chamber
In Publication
University of Parma
Francesca Buttini
Comparing Carbon Emissions for Three Dry Powder Inhaler Technologies
In Publication
University of Parma
Francesca Buttini
Effect of Ethanol Content and Actuator Orifice Diameter on the Performance of Salbutamol Sulfate pMDI Suspensions in HFO1234ze(E)
In Publication
University of Parma
Francesca Buttini
Tailoring of a Pramlintide Pulmonary Dry Powder for Diabetes and Obesity Treatment
In Publication
University of Sydney
Dipesh Khanal
Optical Photothermal Infrared Spectroscopic Assessment of Fluticasone/Salmeterol/Lactose Co-Association in Advair Diskus® and Wixela Inhub®
In Publication
Lara Penn
Successful Scale-Up of a Spray Dried Formulation for Nasal Drug Delivery
In Publication
Vast Therapeutics
Mark Schoenfisch
Efficacy of Inhaled ALX1 in a Model of Chronic Pseudomonas Aeruginosa Infection
In Publication
Fraser Carr
Exploration of Alternative Methodologies for Spray Pattern Evaluation in a Budesonide/Formoterol Fumarate Dihydrate pMDI
In Publication
Philip Smith
Bio-Based Plastics for Medical Devices: A Case Study
In Publication
Raneem Aldaqqa
Designing mRNA Lipid Nanoparticles for Tumor Associated Macrophages: Towards Immunotherapies for the Treatment of Osteosarcoma Lung Metastases
In Publication
Caleb Dalton
Pharmaceutical Aerosol Deposition in a Stainless-Steel Version of the VCU Mouth-Throat Models
In Publication
Caleb Dalton
Spray Characterization of Low Volume Air-Jet Dry Powder Inhaler Devices for the Delivery of a Synthetic Lung Surfactant Powder Formulation
In Publication
Victoria Garcia
Locally Administered Gemcitabine Chemotherapy for the Treatment of Osteosarcoma Lung Metastases
In Publication
FH
Felicia Hall
Comparison of In Vitro Aerosol Performance and Powder Characteristics of a Synthetic Lung Surfactant Powder Aerosol Formulation Produced using Two Spray Drying Methods
In Publication
Rudra Pangeni
Efficient Delivery of Powder Aerosol to the Lungs of Small Animals with a New Air-Jet Dry Powder Insufflator
In Publication
Surendra Poudel
In Vivo Efficacy of Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas Aeruginosa Lung Infection Model
In Publication
Masahiro Sakagami
A Novel Hybrid Molecule of Melatonin and Curcumin: In Vivo Therapeutic Intervention in the Rat Model of Lung Fibrosis with Local Lung Delivery
In Publication
Morgan Thomas
Advancements in Complete-Airway Modeling of Pharmaceutical Aerosols: Implementation of a Tracheobronchial Voluming-Filling Algorithm
In Publication
Woolcock Institute of Medical Research
Patrick He
Comparison of In Vitro Aerosol Deposition by Salbutamol pMDI with Corrugated Tubing and Commercial Spacer
In Publication
Zenius
Yui Muguruma
In Vitro Aerosol Delivery Performance of the Zenius Prototype Inhaler
In Publication

Preparing and Displaying a Poster

Posters give you the opportunity to display innovative research and technology and interact face-to-face with conference delegates. You are also strongly encouraged to prepare an on-demand recorded presentation to share your work with all delegates. These will be posted in the appropriate online Knowledge Space through June 30 (see On-Demand Narrated Presentation Guidelines below). Taking this extra step allows all delegates to ask you questions using Messaging and means you are ready if invited to participate in Posters on the Podium.

Maximum size of your poster is 45 inches (1.1 meters) tall and 90 inches (2.2 meters) wide. Designs using text and easily interpreted, eye-catching graphics readable from 6 feet (1.8 meters) garner most attention. Focus on one or two themes and keep the design simple to emphasize your main findings. There’s no need to include a lot of background information.

Poster content must be closely related to your published abstract with all claims and conclusions supported by data or references. Do not include wildly speculative or unsubstantiated comments.

We will provide supplies to mount your posters on a board. A skirted, 15-inch (0.4 meter)-wide table beneath your poster will allow distribution of copies of your poster and other literature. It also facilitates demonstrations of small handheld devices or use of a laptop, but is unsuitable for anything heavier than 10 lbs. Posters do not have access to electricity.

Please be present at your poster to answer questions for at least an hour each time the dedicated Poster and Exhibition is scheduled. If you do not intend to stay the whole time, it is helpful to display a sign showing when you will be present. Messaging will also be available via the Conference website to encourage discussion with delegates.

If you need to ship your poster rather than hand-carry, see Shipping Instructions below.

Poster Set-up and Take-down

  • Set-up is encouraged on Sunday, May 5, between 3:00 PM to 7:00 PM. Please register at the Registration Desk in the lower level of the conference hotel and immediately proceed to the Tucson Ballroom. Our staff will direct you to your table location. Do not set up in a different location. Late arrivals may set up on Monday, May 6, from 7:30 to 9:00 AM.
  • To protect your property, hotel security will not allow access to the Poster and Exhibition area from Sunday at 7:00 PM until Monday at 7:30 AM. We recommend that you take small, high-value items such as laptops and prototype devices with you when you are not at your poster or when leaving the space for the evening.
  • A Poster and Exhibition Floor Plan will be provided to all registrants.
  • Posters must be removed at 7:00 PM on Tuesday, May 7.

Disclaimer

The meeting organizers and the JW Marriott Starr Pass expressly disclaim responsibility for loss or damage to any items you bring into the Poster and Exhibition space.

On-Demand Narrated Presentations Guidelines for All Presenters - Due April 12, 2024

We ask poster presenters to create a compelling 10-minute narrated slide presentation that will be posted on the Conference website and visible to all delegates through June 30. The RDD audience is familiar with many aspects of nasal and pulmonary delivery so keep the background short. Focus on clearly presenting data and conclusions in your abstract. Ensure all claims, especially those that mention competitors, are supported by data or references. Do not include wildly speculative or unsubstantiated comments.

Approximately 8 slides should first be prepared using PowerPoint before using the recording function to add your voice-over narration. Presentations that exceed 10 minutes may end abruptly once posted on our platform. Practice your timing before making your final recording.

We offer the following as a guide:

Slide Count

  • 1 Slide: Shows your presentation title (exactly the same as your poster abstract), names of all presenters and their institution(s). Optionally, include contact information and the presenter's photo. Please note that you are consenting to this information being visible to delegates on all RDD websites when you send us your slides
  • 1 Slide: Background / Introduction
  • 1 or 2 Slides: Methods
  • 3 or 4 Slides: Data / Conclusions

Slide Preparation

  • Prepare your slides in 16 X 9 format.
  • Some delegates will be viewing your slides on a small screen. Don’t allow busy slides, small fonts, complex backgrounds and institutional logos to diminish your message.
  • Figures and photographs should be clearly visible.
  • Ensure the axes on graphs are clearly labeled and that highly visible lines or symbols differentiate among data sets. Provide a key. Do not include graphic elements you will not discuss in the text.

Voice-over Narration

Adding your voice-over narration is easy. This How-To-Video supplements the summary below.

  • Prepare to record in a quiet location.
  • Open your presentation and click the Slide Show tab.
  • Check that your microphone is set up correctly. A headset microphone often produces the best quality audio.
  • Select the slide where you want the recording to begin, then click Record Slide Show and start talking.
  • Click End Show to stop recording.
  • A Save dialog box appears. Click Yes to save your recording, or No if you want to record it again. Saving overwrites anything you've previously recorded. It is possible to re-record individual slides.
  • Click Play from Start to review your recording.

Submit Your File

Send your final PowerPoint (.pptx) file to info@rddonline.com before April 12, 2024.

Send your final PowerPoint (.pptx) file

If the file is too large to e-mail, your organization may have a preferred file transfer protocol (FTP), but if not, we recommend using wetransfer.com.

Shipping Instructions

Please ensure anyone shipping packages to the JW Marriott Starr Pass on your behalf receives a copy of these instructions. JW Marriott Starr Pass uses PostNet, located in the onsite business center, to coordinate Shipping and Receiving.


PostNet Shipping & Receiving Contact: Magda Good (magda.good@postnet.com) / 520-791-6140
Shipping and Receiving hours are 8:00 am–5:00 pm Monday through Friday.

SHIPPING SCHEDULE

Shipments should be timed to arrive between Monday, April 29, and Friday, May 3, 2024. Packages arriving outside these dates may be subject to additional PostNet storage fees as shown at the end of this document.

HANDLING FEES

Handling and storage fees will be levied and collected by PostNet for incoming and outgoing packages. If you are staying at the JW Marriott Starr Pass, charges will be added to your room. If not, PostNet will request payment by credit card according to the PostNet fee schedule.

LABELING YOUR SHIPMENT

Please attach a Main Shipping Label and Auxiliary Shipping Label to each box clearly showing the following information:

IMPORTANT INFORMATION

RDD 2024 does not accept responsibility for items delayed, lost, or damaged in transit to or from the JW Marriott Starr Pass.

  • Shipments will be brought to your exhibit table, poster location, or workshop room.
  • All international shipments are subject to customs inspection. Please ensure sufficient time for customs clearance and include “Items for trade demonstration and re-export” on the Auxiliary Shipping Label and documentation.
  • Transport and custom charges are the responsibility of the sender. Neither RDD nor the JW Marriott Starr Pass will pay transport or customs fees. Please ensure all transport and customs fees are prepaid.
  • Package fragile equipment carefully. Dangerous or suspicious looking materials should not be shipped to RDD 2024.
  • Oversize packages must be coordinated with PostNet in advance of delivery: Oversize packages (including pallets) are those that exceed any one or more of the following parameters: Height of 84” or taller, wider than 66”, greater than 300 pounds, requiring forklift, and others as determined by PostNet.

OUTGOING SHIPMENTS

  • You are responsible for organizing the packing and outgoing shipment of your materials (pack a roll of tape).
  • PostNet will collect prepaid/prelabelled outgoing packages from your exhibit table, poster, or workshop room; you will not need to schedule pick-up. FedEx, USPS, UPS and DHL (International only) provide daily weekday service to the area.
  • PostNet can arrange outgoing shipments for major carriers. Please take packages to the PostNet office (they will not be picked up from your exhibit table without a prepaid label). If you do not have an account number, you will need to make payment by credit card.

Questions?

For further information, contact Richard Dalby.

↑ Back to Top